JAVMA news
Groups seek combined oversight of research animals
Four organizations in research and human medicine support combining federal oversight over research animals.
JAVMA news
Mississippi State creates host-pathogen interaction center
Mississippi State University has been awarded a $10 million grant for five years of support from the National Institutes of Health to further research…
Disposal of pharmaceuticals
Pharmaceutical Disposal has come under increased scrutiny due to detection of human pharmaceuticals in U.S. Waterways.
JAVMA news
AVMA may change guidance for CO2 euthanasia in rodents
Pending revisions to the AVMA's euthanasia guidelines likely will instruct veterinarians to use faster flow rates when using carbon dioxide
JAVMA news
$4.8M grant funds work on vaccine for coccidioidomycosis
The National Institutes of Health has awarded a four-year, $4.8 million grant to the University of Arizona College of Medicine-Tucson to fund work on
JAVMA news
AVMA emphasizes responsible stewardship of laboratory animals
The AVMA has revised the policy "Use of Animals in Research, Testing, and Education" to balance the emphasis placed on the importance of animal-based…
JAVMA news
Animal research helps pets, too
This past October, the Foundation for Biomedical Research launched its "Love Animals? Support Animal Research" campaign to educate the public about…
JAVMA news
Database lists clinical studies on cannabis, cancer, more
Cannabis is just one focus of current clinical trials involving animals, with others focusing on treatments such as stem cells and monoclonal…
JAVMA news
Finding a future for osteosarcoma patients
Ana M. Cilursu, MD, lost three Rottweilers in a row to bone cancer.
JAVMA news
Vaccine holds promise for treating osteosarcoma in dogs
Veterinarians in the audience wanted to know when they could get their hands on the new treatment. Dr. Sue Ettinger, a veterinary oncologist, had…
JAVMA news
A glimmer of hope for a fatal feline disease
Controlling risk factors for feline infectious peritonitis is difficult, while new antiviral drugs show great promise